• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by PetVivo Holdings Inc. (Amendment)

    5/9/24 5:31:09 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care
    Get the next $PETV alert in real time by email
    SC 13G/A 1 sc13g-amend.htm AMENDMENT NO. 2 TO SCHEDULE 13G

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

     

    PetVivo Holdings, Inc.

    (Name of Issuer)

     

    Common Stock, (Nasdaq: PETV)

    (Title of Class of Securities)

     

    716817408

    (CUSIP Number) 

     

    April 29, 2024

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐  Rule 13d-1(b)
       
    ☒  Rule 13d-1(c)
       
    ☐  Rule 13d-1(d)
       

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     
     

     

    CUSIP No. 716817408 SC 13G/A Page 2 of 5 Pages

     

    1

     

    NAME OF REPORTING PERSON

     

    A.L. Sarroff Fund, LLC [1] 

    2

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)   ☐

    (b)   ☐ 

    3

     

    SEC USE ONLY 

     

    4

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States 

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

    5

     

    SOLE VOTING POWER

     

    2,718,544 common stock [2] 

     

    6

     

    SHARED VOTING POWER

     

    0 

     

    7

     

    SOLE DISPOSITIVE POWER

     

    2,718,544 common stock [2] 

     

    8

     

    SHARED DISPOSITIVE POWER

     

    0 

    9

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    2,718,544 common stock [2] 

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐ 

    11

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    16.21% [3] 

    12

     

    TYPE OF REPORTING PERSON

     

     PN [4]

     

     

    [1] A.L. Sarroff Fund, LLC (the "Company") is a New York Limited Liability Company (LLC) whose two individual members own, respectively, 90% and 10% of the Company's membership interests. The securities reported in this Schedule 13G were acquired primarily in accounts in the name of the Company and partly in accounts in the names of the two individual members.

    [2] In addition to the common shares reported in this Schedule 13G, the Company owns and/or controls 1,166.668 Warrants of the issuer, exercisable as of February 11, 2024, i.e., six months rather than sixty days from the date of their acquisition. These Warrants have not been exercised. Pursuant to SEC Rule 13d-3(d) (1), these Warrants are therefore not included in the Company's aggregate shareholdings for purposes of this Schedule G.

    [3] According to the issuer's latest Form 10-Q, there were 16,770,018 outstanding common shares as of December 31, 2023. The common shares owned and/or controlled by the Company as of December 31, 2023 totaled 11.75% of the common shares outstanding. 

    [4] This filing is made in reliance upon SEC Rule 13d-1(c). The Company, (a) has not acquired the securities with any purpose, or with the effect, of changing or influencing the control of the issuer, or in connection with or as a participant in any transaction having that purpose or effect, including any transaction subject to Rule 13d-3(b); (b) is not a person reporting pursuant to SEC Rule 13d-1(b)(1); and (c) is not directly or indirectly the beneficial owner of 20 percent of more of the class. 

     
     
     

     

    CUSIP No. 716817408 SC 13G/A Page 3 of 5 Pages

     

      Item 1(a). NAME OF ISSUER:

             

                          The name of the issuer is PetVivo Holdings, Inc.

     

      Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

                            
                          5251 Edina Industrial Blvd., Edina, Minnesota, 55349.

     

      Item 2(a). NAME OF PERSON FILING:

                         
                          A.L. Sarroff Fund, LLC .

     

      Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

             

                          43 Meadow Woods Road, Great Neck, NY 11020

      Item 2(c). CITIZENSHIP:

             

                         United States.

     

      Item 2(d). TITLE OF CLASS OF SECURITIES:

             

                         Common stock.

     

      Item 2(e). CUSIP NUMBER:


                        716817408                                 

     

      Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a)   ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

     

      (b)   ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

     

      (c)   ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

     

      (d)   ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);

     

      (e)   ☐ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

     

      (f)   ☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

     

      (g)   ☐ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     

      (h)   ☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

      (i)   ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     

      (j)   ☐ A non-U.S. institution, in accordance with §240.13d-1(b)(1)(ii)(J);

     

      (k)   ☐ Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:___.

     

     
     
     

     

    CUSIP No. 716817408 SC 13G/A Page 4 of 5 Pages

     

      Item 4. OWNERSHIP

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

    (a)   Amount beneficially owned: 2,718,544 common stock

     

    (b)   Percent of class: 16.21%

     

    (c)   Number of shares as to which such person has:

     

      (i)   Sole power to vote or to direct the vote    2,718,544 common stock

     

      (ii)   Shared power to vote or to direct the vote    0

     

      (iii)   Sole power to dispose or to direct the disposition of  2,718,544 common stock

     

      (iv)   Shared power to dispose or to direct the disposition of     0

     

      Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.


    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following [ ].

    Not applicable.

     

      Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

            

    Not applicable.

     

      Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON.

             

    Not applicable.

     

      Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

     

    Not applicable.

     

      Item 9. NOTICE OF DISSOLUTION OF GROUP.

             

    Not applicable.

     

      Item 10. CERTIFICATION.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     
     

    CUSIP No. 716817408 SC 13G/A Page 5 of 5 Pages

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

      

    A.L. Sarroff Fund, LLC

     

     

    /s/ Alan L. Sarroff  
    Alan L. Sarroff  
    Title: Chief Executive Officer and Managing Member  

      

     

    DATED: May 9, 2024 

     

     

     

     

     

     

    Get the next $PETV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PETV

    DatePrice TargetRatingAnalyst
    10/12/2021$7.00Buy
    ThinkEquity
    More analyst ratings

    $PETV
    SEC Filings

    See more
    • PetVivo Holdings Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement

      8-K - PetVivo Holdings, Inc. (0001512922) (Filer)

      5/7/25 11:48:49 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • SEC Form 8-K filed by PetVivo Holdings Inc.

      8-K - PetVivo Holdings, Inc. (0001512922) (Filer)

      4/8/25 3:35:35 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • SEC Form SCHEDULE 13G filed by PetVivo Holdings Inc.

      SCHEDULE 13G - PetVivo Holdings, Inc. (0001512922) (Subject)

      4/4/25 4:40:47 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Lai John bought $90,000 worth of shares (150,000 units at $0.60), increasing direct ownership by 13% to 1,288,592 units (SEC Form 4)

      4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      4/17/24 5:28:07 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by PetVivo Holdings Inc.

      SC 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)

      11/19/24 3:38:53 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by PetVivo Holdings Inc.

      SC 13G - PetVivo Holdings, Inc. (0001512922) (Subject)

      11/4/24 1:57:37 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by PetVivo Holdings Inc.

      SC 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)

      10/1/24 5:26:09 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Leadership Updates

    Live Leadership Updates

    See more
    • PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor

      PetVivo Board Appoints Eldred as Executive Director to Lead Company Product Commercialization and Operations MINNEAPOLIS, MN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, PETVW)), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Mike Eldred as the Company's Commercialization and Operations Advisor. His appointment as an Executive Director by the Company's Board of Directors draws upon Mr. Eldred's 30 years of executive experience in animal health and the veterinary industry to ramp up its product development and sales efforts. For the past 20 years, Mr. Eldred served as President of North American Operations for Dech

      1/27/25 9:29:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PetVivo Engages Another Top Sales Manager, Cindy Gill, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide

      MINNEAPOLIS, MN, Oct. 21, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, PETVW))), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Cindy Gill to the position of field veterinary business development manager for the entire states of Oklahoma and Arkansas and the northern region of Texas. "Cindy's experience and strong record of sales achievement with veterinary clinics brings to our sales team a valuable resource for achieving our business goals," PetVivo CEO, John Lai. "Her experience with other veterinary products and her knowledge of clinic operations enables her to prioritize and better address the veterinarians and cli

      10/21/24 9:45:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PetVivo Taps Top Sales Executive, Skylor Walker, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide

      MINNEAPOLIS, MN, Sept. 16, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, PETVW))), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Skylor Walker to the new position of field veterinary business development manager for the entire state of Louisiana and the southern region of Texas. "Skylor's experience and strong record of sales achievement with veterinary clinics brings to our sales team a valuable resource for achieving our business goals," PetVivo CEO, John Lai. "Her experience with other hydrogel injectable products enables us to prioritize and better address the veterinarians and clinics in our sales pipeline."

      9/16/24 8:00:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ThinkEquity initiated coverage on PetVivo Holdings with a new price target

      ThinkEquity initiated coverage of PetVivo Holdings with a rating of Buy and set a new price target of $7.00

      10/12/21 11:03:37 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DIGITAL LANDIA, LLC IN COOPERATION WITH PETVIVO HOLDINGS, INC. UNVEILS REVOLUTIONARY AUTONOMOUS PET AI ECOSYSTEM TRANSFORMING PET CARE WITH SELF-LEARNING MULTI-AGENT AI TECHNOLOGY

      MIAMI, FL, May 13, 2025 (GLOBE NEWSWIRE) -- Digital Landia, LLC, in cooperation with PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW) and its wholly owned subsidiary PetVivo Animal Health, Inc. (collectively referred to herein as "PetVivo"), today announces the upcoming launch of AgenticPet.ai, the world's first autonomous pet care AI ecosystem that leverages cutting-edge multi-agent technology to revolutionize how we understand and care for our animal companions. Set for public release on May 23, 2025, this groundbreaking platform creates specialized AI agents that continuously learn and evolve to provide unprecedented insights into pet health and wellness. "AgenticPet.ai represents a para

      5/13/25 7:00:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES

      MINNEAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for equine and companion animals, announced today it has entered into a definitive distribution agreement with Eq Especialidades ("Eq Especialidades"). Eq Especialidades will inventory, market and promote PetVivo's veterinary medical device, Spryng™ with OsteoCushion™ technology, throughout Mexico. Eq Especialidades sales and marketing activities will commence on April 1, 2025. SPRYNG® with OsteoCushion® Technology, is an intra-articular injectable veterinary m

      4/16/25 9:30:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF SERIES B CONVERTIBLE PREFERRED STOCK OFFERING

      MINNEAPOLIS, March 31, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the "Company") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for horses, dogs and other companion animals announced today that the Company has recently entered into a Subscription Agreement to receive Five Million Dollars ($5,000,000) of equity financing in exchange for Five Million shares of Series B Convertible Preferred Stock ("Shares") (the "Offering"). The Company initially received Six Hundred Thousand Dollars ($600,000) of the Offering proceeds

      3/31/25 8:00:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Eldred Michael Eugene claimed ownership of 106,250 shares (SEC Form 3)

      3 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      5/20/25 2:36:40 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Lowenthal Garry N was granted 29,412 shares (SEC Form 4)

      4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      5/20/25 2:12:22 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Lowenthal Garry N was granted 75,000 shares (SEC Form 4)

      4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      4/15/25 4:36:36 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Financials

    Live finance-specific insights

    See more
    • PetVivo Reports Fiscal Q3 2025 Results

      MINNEAPOLIS, MN, US, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW), a leading biomedical company delivering innovative therapeutics and medical devices for equines and companion animals, reported results for its fiscal third quarter ended December 31, 2024. All comparisons are to the same year-ago period unless otherwise noted. The company will hold a conference call today at 3:00 p.m. Eastern time to discuss the results for the period (see dial-in information below). Fiscal Q3 2025 Financial Highlights Revenues totaled $583,000, up 191% sequentially and declined 2% from the same year ago period, reflecting the company's continued efforts from targetin

      2/14/25 3:10:00 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024

      MINNEAPOLIS, MN, US, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Friday, February 14, 2025 after market close. The company will host a conference call to discuss these results at 2:00 p.m. CT (3:00 p.m. ET) on the same day. Attendees of the live webcast of the conference call and related earnings release materials can register and access the webcast on PetVivo's Investor Relations website at: https://audience.mysequire.com/webinar-view?webinar_id=b5c71aaf-5545-4297-93c3-e23bfb001608. A replay of the

      2/11/25 10:15:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PETVIVO HOLDINGS, INC. TO HOST SHAREHOLDERS UPDATE MEETING ON JANUARY 8, 2025

      MINNEAPOLIS, MN, US, Dec. 30, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will host a live webcast Shareholders Update Meeting to provide an overview of the Company's progress in the 2025 fiscal year and a look into the potential future of the Company. The Shareholders Update Meeting: 2025 Company Overview will be held on Wednesday, January 8, 2025 at 3:30 p.m. CT (4:30 p.m. ET). Attendees of the Shareholders Update Meeting live webcast and conference call can register and access the webcast on PetVivo's Investor Relations website at: https://audience.m

      12/30/24 10:23:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care